TaSMT-5B gene for improving wheat scab resistance and application of TaSMT-5B gene
Through the overexpression of TaSMT-5B gene and inorganic selenium treatment, the resistance to gibberellosis in wheat was significantly improved, and the problem of insufficient research on the resistance effect of gibberellosis in the prior art was solved, thus significantly reducing the spikelet rate effect.
Patent Information
- Application Number
- CN202410862015.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-28
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-06-28
AI Technical Summary
In the prior art, there are few studies on the resistance effect and mechanism of wheat SMT on gibberellia, and there is a lack of effective genes for improving wheat resistance to gibberellia.
The TaSMT-5B gene and its encoded protein are provided, and the gibberellosis resistance of wheat is enhanced by constructing a recombinant vector and introducing it into the host cell.
The resistance of wheat to gibberellosis is significantly improved. Through the overexpression of TaSMT-5B gene and inorganic selenium treatment, the spikelet rate can be reduced by 20% to 50%.
Smart Images

Figure CN119082151A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to a TaSMT-5B gene for improving wheat scab resistance and an application thereof. Background Art
[0002] Wheat fusarium head blight is mainly caused by the Fusarium graminearum complex. The pathogenic fungus can reproduce and spread through two forms: ascospores and conidia. During the flowering period of wheat, it colonizes in spikelets by infecting anthers and glumes, and uses the vascular bundle to spread from the spikelet axis to other spikelets, eventually causing the wheat grains to shrivel, reduce vitality, and accumulate various fungal toxins such as deoxynivalenol (DON), which seriously threatens grain production and food safety. Selenocysteine methyltransferase (SMT) is a key enzyme that catalyzes the methylation of selenocysteine (SeCys) to form methylselenocysteine (MeSeCys) during plant selenium metabolism. MeSeCys is an important precursor of methylselenium, which has antioxidant and heavy metal detoxification effects. Studies have shown that selenium forms such as MeSeCys can significantly inhibit the growth of Fusarium graminearum; the accumulation and volatilization of MeSeCys can also help wheat prevent and respond to the invasion of Fusarium graminearum. To date, there are still few reports on the effects and mechanisms of wheat SMT on resistance to Fusarium fusarium. Summary of the invention
[0003] The purpose of this section is to summarize some aspects of embodiments of the present invention and briefly introduce some preferred embodiments. Some simplifications or omissions may be made in this section and the specification abstract and the invention title of this application to avoid blurring the purpose of this section, the specification abstract and the invention title, and such simplifications or omissions cannot be used to limit the scope of the present invention.
[0004] In view of the above problems and / or the problems existing in the prior art, the present invention is proposed.
[0005] Another object of the present invention is to overcome the deficiencies in the prior art and provide a gene TaSMT-5B.
[0006] In order to solve the above technical problem, the present invention provides the following technical solution: the nucleotide sequence of the gene is shown as SEQ ID NO.1.
[0007] Another object of the present invention is to overcome the deficiencies in the prior art and provide a TaSMT-5B protein encoded by the gene TaSMT-5B.
[0008] As a preferred embodiment of the TaSMT-5B protein encoded by the gene TaSMT-5B of the present invention, the TaSMT-5B protein is one of the proteins shown in (i) to (iv) below:
[0009] (i) the protein whose amino acid sequence is shown in SEQ ID NO.2;
[0010] (ii) a protein derived from SEQ ID NO. 2 having the same function as that of SEQ ID NO. 2, wherein one or more amino acid residues are substituted and / or deleted and / or added;
[0011] (iii) a protein having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence shown in SEQ ID NO. 2 and its derivative protein and having the same function;
[0012] (iv) A fusion protein obtained by connecting a tag to the N-terminus and / or C-terminus of the amino acid sequence shown in SEQ ID NO.2 and its derivative proteins or homologous proteins.
[0013] Another object of the present invention is to overcome the deficiencies in the prior art and provide a recombinant vector containing the gene TaSMT-5B.
[0014] As a preferred embodiment of the recombinant vector containing the gene TaSMT-5B described in the present invention, it includes: the nucleotide sequence of the recombinant vector is as shown in SEQ ID NO.3, which is obtained by inserting the amino acid sequence encoded by the TaSMT-5B gene between the restriction endonucleases HindIII and BamHI in the multiple cloning site of the pCambia3300 backbone vector.
[0015] Another object of the present invention is to overcome the deficiencies in the prior art and provide a transformant. The recombinant vector is introduced into a host cell, and the host cell is preferably an Escherichia coli cell or an Agrobacterium cell.
[0016] Another object of the present invention is to overcome the deficiencies in the prior art and provide a gene TaSMT-5B, TaSMT-5B protein, recombinant vector or transformant for use in improving wheat resistance to fusarium head blight.
[0017] Another object of the present invention is to overcome the deficiencies in the prior art and provide a gene TaSMT-5B, TaSMT-5B protein, recombinant vector or transformant for use in wheat breeding, so as to obtain a wheat variety with significant disease resistance after introduction into plants.
[0018] As a preferred solution of the application of the present invention, it includes: TaSMT-5B gene overexpression combined with inorganic selenium-based application. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for describing the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative labor. Among them:
[0020] Figure 1 is the CDS of TaSMT-5B in China Spring (CS), Zheng 9023 and Ximai 1376 in Example 1 of the present invention ( Figure 1 A) and promoter ( Figure 1 B) Sequence alignment diagram.
[0021] Figure 2 This is a diagram of the spatiotemporal expression pattern of the TaSMT-5B gene in Example 1 of the present invention.
[0022] Figure 3 This is a map of the vector construction in Example 1 of the present invention.
[0023] Figure 4 This is a positive identification diagram of transgenic in Example 1 of the present invention.
[0024] Figure 5 This is the expression detection diagram of the positive strain in Example 1 of the present invention.
[0025] Figure 6 This is the Fusarium fusarium phenotype of the TaSMT-5B overexpressing transgenic material in Example 1 of the present invention.
[0026] Figure 7 These are the statistical results of the diseased ear rate of the Fusarium fusarium phenotype of the TaSMT-5B overexpressing transgenic material in Example 1 of the present invention. DETAILED DESCRIPTION
[0027] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with the embodiments of the specification.
[0028] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein, and those skilled in the art may make similar generalizations without violating the connotation of the present invention. Therefore, the present invention is not limited to the specific embodiments disclosed below.
[0029] Secondly, the term "one embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present invention. The term "in one embodiment" that appears in different places in this specification does not necessarily refer to the same embodiment, nor does it refer to a separate or selective embodiment that is mutually exclusive with other embodiments.
[0030] Unless otherwise specified, the raw materials used in the examples of the present invention are commercially available.
[0031] Using the genome of wheat variety Chinese Spring as a reference, the CDS sequence of TaSMT-5B gene in Chinese Spring, Zheng 9023 and Ximai 1376 is completely consistent (sequence alignment see Figure 1 A), but the promoter region of this gene has a "GTCGCCG" insertion site (located 1742 bp upstream of the start codon) in Zheng 9023, which is highly enriched in MeSeCys and highly resistant to ergot, while there is no such insertion site in China Spring and Ximai 1376 (sequence alignment see Figure 1 B). Quantitative analysis of Zheng 9023 and Ximai 1376 at different time points and tissue locations revealed that the expression of this gene was induced by selenium and was more stable in Zheng 9023. The highest expression level was found in the wheat ear 24 hours after selenium treatment ( Figure 2 ), which is the key part of Fusarium graminearum infection and expansion. Therefore, we extracted RNA from Zheng 9023, reverse transcribed it to obtain cDNA, amplified the CDS sequence of TaSMT-5B, and carried out vector construction, genetic transformation, inorganic selenium treatment and phenotypic identification of Fusarium graminearum. The nucleotide sequence of TaSMT-5B gene is shown in SEQ ID NO:1 in the sequence table, and its protein amino acid sequence is shown in SEQ ID NO:2.
[0032] Example 1
[0033] (1) Wheat RNA extraction and reverse transcription:
[0034] Ⅰ. RNA extraction:
[0035] Preparation: Sample, 2mL / 1.5mL enzyme-free centrifuge tube, enzyme-free pipette tip, Trizol, chloroform, isopropanol, 75% ethanol, DEPC-treated H2O, centrifuge precooled at 4℃.
[0036] Quickly take out the sample from liquid nitrogen and put it in a pre-cooled mortar, grind it into powder, take an appropriate amount of powder into a 2mL enzyme-free centrifuge tube, put the centrifuge tube on ice, add 1mL Trizol, put it on a shaker and shake for 30s to fully lyse it, then add 400μL of chloroform, put it on a shaker and shake it for 15s, let it stand for 3min, put it in a centrifuge, set it at 4℃, 12000rpm, and centrifuge for 15min;
[0037] Pipette 400 μL of supernatant into a 1.5 mL enzyme-free centrifuge tube, add isopropanol at a ratio of 1:1, flip upside down 5-10 times to mix, and place in -20°C for 30 minutes to precipitate RNA. After precipitation, place in a centrifuge, set at 4°C, 12000 rpm, and centrifuge for 15 minutes;
[0038] Take out the centrifuge tube, discard the supernatant, add 1 mL of 75% ethanol (prepared with DEPC-treated water), wash the RNA precipitate, put it into the centrifuge, set it at 4°C, 12000 rpm, centrifuge for 5 minutes, discard the supernatant, centrifuge for 10-20 seconds, and use an enzyme-free pipette to absorb the residual ethanol;
[0039] Place the centrifuge tube in a clean bench and blow it for 15-20 minutes until it becomes transparent, add preheated 70°C DEPC water and dissolve it for 5 minutes.
[0040] Store the extracted RNA in a -80℃ refrigerator.
[0041] Ⅱ. Reverse transcription of cDNA using a reverse transcription kit (Novozyme, Nanjing):
[0042] 1. Removal of genomic DNA:
[0043] Table 1
[0044]
[0045] PCR program: 42°C, 2 min.
[0046] 2. Reverse transcription of cDNA:
[0047] Table 2
[0048]
[0049] PCR program: 50℃ for 15min; 85℃ for 2min. The reverse transcription product was stored at -20℃.
[0050] (2) Real-time fluorescence quantitative PCR:
[0051] The primers used for quantification were designed based on the reference genome, and the sequences are as follows:
[0052] The forward primer was: TCTCCATTCGGAAGGTCACAG (SEQ ID NO: 4);
[0053] The reverse primer is: TATTGCCCTGATGGTGTTTGG (SEQ ID NO: 5);
[0054] Real-time fluorescence quantitative PCR: Prepare 10 μL of quantitative PCR system as follows:
[0055] Table 3
[0056]
[0057] PCR program: pre-denaturation: 95°C for 30 s; cycle reaction: 95°C for 5 s, 60°C for 34 s, 40 cycles; melting curve: 95°C for 15 s, 60°C for 60 s, 95°C for 15 s.
[0058] (3) Construction of transgenic vector:
[0059] Primer premier 5 primer design software was used to design the construction primers for the transgenic overexpression vector. The primer sequences were as follows: forward primer: CCCAAGCTTATGGTGGTGAAGAGCGGAG (SEQ ID NO: 6) and reverse primer: CCCAAGCTTTGCTGCTGGGTAGTATTGGTT (SEQ ID NO: 7); the primers were synthesized by Nanjing GenScript Co., Ltd.
[0060] The CDS sequence of TaSMT-5B was amplified using the cDNA of Zheng 9023 as a template. The reaction system was as follows:
[0061] Table 5
[0062]
[0063]
[0064] PCR program: 94°C for 3 min; 98°C for 30 s, 56°C for 30 s, 68°C for 1.5 min, 30 cycles; 68°C for 10 min; the product was stored at 4°C.
[0065] Agarose gel purification of PCR products:
[0066] 1. Prepare 2% agarose gel with TAE electrophoresis buffer solution and add 1% volume of 0.5 mg / mL EB during gel preparation;
[0067] 2. Add 5 μL 10× loading buffer to the PCR product, load all samples into the gel wells, spot Trans2kDNA Marker in the empty wells, and perform electrophoresis at 130V for 15 minutes;
[0068] 3. Under UV light (Bio-RAD), cut the gel block with a clean blade (the size of the band matches the size of the target fragment) and put it into a 2.0 mL centrifuge tube;
[0069] 4. Recover the target fragment according to the instructions of the gel recovery kit (Sangon, China).
[0070] Ligation cloning vector pEASY-Blunt3:
[0071] Preparation system:
[0072] Table 6
[0073]
[0074] PCR program: 25°C for 30 min.
[0075] Transform the ligation product into competent E. coli cells:
[0076] 1. Take out the Fast-T1 competent cell suspension and thaw it on ice, then pipette 50 μL of competent cells and mix with all the products in the previous step, pipette and beat to mix, and place on ice for 30 min;
[0077] 2. Heat shock it in a metal bath at 42°C for 1 min 30 s. After the heat shock is completed, quickly put it in an ice bath for 3-5 min, then add 1 mL of LB liquid culture medium, pipette and mix, put it in a shaker, set it at 37°C, 150 rpm, and culture it for 1 h.
[0078] 3. After the culture is completed, centrifuge at 5000 rpm for 5 minutes, discard the supernatant, use a pipette to gently mix the precipitate with the remaining liquid culture medium in the tube, and then spread it on the LB solid culture medium with ampicillin (Amp) resistance. Seal the plate with a sealing film and place it upside down in a 37°C incubator overnight;
[0079] 4. After obvious E. coli colonies grow, select 10 bacterial spots and perform PCR detection on positive strains;
[0080] The PCR reaction system is as follows:
[0081] Table 7
[0082]
[0083] PCR program: 95°C, 3 min; 95°C, 30 s, 56°C, 30 s, 72°C, 1.5 min, 28 cycles; 72°C, 5 min;
[0084] 5. Identify with 2% agarose gel. Observe with UV light of the gel imaging system (Bio-RAD), select positive clones and put them into LB liquid culture medium (containing Amp), place them on a shaker at 180 rpm and culture them at 37°C overnight.
[0085] 6. After the positive strains were identified, the bacterial culture was sent to Genewise (Suzhou, China) for sequencing.
[0086] 7. Use DNAMAN software to compare and verify the sequencing results with the target sequence.
[0087] The strain with the correct sequencing results was selected and the plasmid was extracted and digested according to the instructions of the plasmid DNA small-scale extraction kit (Sanggong, China).
[0088] Prepare 50 μL of enzyme digestion reaction system, the components are as follows:
[0089] Table 8
[0090]
[0091] PCR program: 37°C for 2h.
[0092] The PCR product was purified by agarose gel and the target fragment was recovered according to the instructions of the gel recovery kit (Sangon, China).
[0093] Ligation of pCambia3300 vector:
[0094] Prepare 10 μL of ligation system, the components are as follows:
[0095] Table 9
[0096]
[0097] PCR program: 25°C for 2h.
[0098] The ligation product was transformed into E. coli Fast-T1 competent cells. After plating overnight, 20 single clones were selected from each bacterial plate for PCR to detect positive strains. After the plasmid was extracted from the positive strains, it was transferred into Agrobacterium EHA105 for the creation of transgenic materials. The constructed vector diagram is shown in the figure below. Figure 3 The nucleotide sequence of the recombinant vector is shown in SEQ ID NO: 3, wherein CaMV 35S Promoter (enhanced) represents the strong promoter of tobacco mosaic virus 35S; BlpR gene, namely Bar gene, can confer herbicide resistance to plants.
[0099] (4) Genetic transformation: The creation of transgenic materials was completed by Tianjin Jinuowo Biotechnology Co., Ltd.
[0100] (5) Positive identification of transgenic genes:
[0101] DNA level identification:
[0102] Extraction of transgenic wheat DNA:
[0103] 1. Grind wheat leaves in a mortar with liquid nitrogen, transfer the fully ground powder to a 2.0 mL centrifuge tube; add 1 mL of 1.5× CTAB extraction solution (1 M Tris-HCl (pH 8.0), 0.5 M EDTA-Na2 (pH 8.0), 5 M NaCl), and shake to mix;
[0104] 2. Stand at 70℃ for 1 hour, shaking every 20 minutes;
[0105] 3. After cooling to room temperature, add 500 μL of chloroform and mix by inverting;
[0106] 4. Let stand for 2 minutes, centrifuge at 12000 rpm for 5 minutes;
[0107] 5. Pipette 600 μL of supernatant into a 1.5 mL centrifuge tube, add an equal volume of isopropanol, mix by inversion, and let stand at -20°C for 30 min;
[0108] 6. Centrifuge at 12000 rpm for 5 min and discard the supernatant;
[0109] 7. Add 1 mL of 75% ethanol to wash the DNA precipitate, centrifuge at 12000 rpm for 5 min, and discard the supernatant;
[0110] 8. After drying, add 100 μL ddH2O to dissolve and set aside.
[0111] BAR gene detection: BAR gene detection primers are as follows:
[0112] Forward primer: CTACATCGAGACAAGCACGGTCAA (SEQ ID NO: 8)
[0113] Reverse primer: AGAAACCCACGTCATGCCAGTTC (SEQ ID NO: 9)
[0114] The following PCR procedure was used for detection. The PCR reaction system is as follows:
[0115] Table 10
[0116]
[0117] PCR program: 95°C, 3 min; 95°C, 30 s, 58°C, 30 s, 72°C, 30 s, 28 cycles; 72°C, 5 min;
[0118] The PCR products were identified using 2% agarose gel. Figure 4 As shown. Among them, the detected gene is BAR gene. 1#, 2#, 3#, 4# and 5# represent 5 transformed strains respectively.
[0119] The expression level identification results are as follows Figure 5 shown.
[0120] Phenotypic analysis of Fusarium fusarium:
[0121] Experimental strains and bacterial solution preparation:
[0122] The Fusarium graminearum used in this experiment is the highly pathogenic Fg0865 (15-ADON chemotype), provided by Professor Chen Huaigu of Jiangsu Academy of Agricultural Sciences. The steps for preparing the inoculation solution are as follows:
[0123] 1. Inoculate the preserved Fusarium graminearum strain onto potato dextrose agar (PDA) solid culture medium and place it in a constant temperature incubator at 25°C for activation culture for 4-5 days.
[0124] 2. Use a sterilized cork borer (7 mm in diameter) to take out the bacterial blocks from the PDA medium and put them into mung bean soup, one bacterial block per 10 mL of mung bean soup. Place it in a shaker at 25°C and 150 r / min and culture for 3-5 days to induce spore production.
[0125] 3. Count the spores using a hemocytometer under a microscope. The spore concentration for inoculation should be at least 1 × 10 5 / μL.
[0126] Fusarium scab inoculation and phenotypic identification:
[0127] In the early stage of wheat flowering, the bacterial solution was injected between the inner and outer lemmas of the florets on both sides of the middle of the wheat by double flower dripping method. The Fusarium spores were identified 12 days after inoculation. The diseased spikelet rate (PSS) = diseased spikelets / total number of spikelets. Phenotypic identification and statistical results are shown in the figure. Figure 6 , 7 shown.
[0128] Figure 1 CDS of TaSMT-5B in China Spring (CS), Zheng 9023 and Ximai 1376 ( Figure 1 A) and promoter ( Figure 1 B) Sequence alignment, the orange arrow indicates a "GTCGCCG" insertion site in the promoter region of Zheng 9023. Figure 2 The temporal and spatial expression patterns of TaSMT-5B in Zheng 9023 and Ximai 1376 were plotted using 2 -ΔΔCq The relative expression was calculated by the method. Figure 5 This is the expression detection of positive strains, where the wild type (WT) is the transgenic recipient variety Fielder, and 1#, 2#, 3#, 4# and 5# represent 5 transformed strains respectively. Figure 6 The wild type (WT) is the transgenic recipient variety Fielder, and 1#, 2#, 3#, 4# and 5# represent 5 transformed strains. The upper part of the figure shows the phenotype of Fusarium head blight under the control treatment; the lower part of the figure shows the phenotype of Fusarium head blight under the treatment of inorganic selenium Na2SeO4, with a total root application of 35 mg / L. The scale bar is 2 cm. Figure 7"PSS" stands for the percentage of symptom spikelets. At least 10 spikelets were inoculated and identified for each transgenic line. Statistical analysis was performed using Student-t test. "*" indicates p<0.05 and "**" indicates p<0.01. Combining inorganic selenium treatment and overexpression of TaSMT-5B gene can reduce the percentage of symptom spikelets by 20% to 50%.
[0129] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention can be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the present invention.
Claims
1. A gene TaSMT-5B, characterized in that: The nucleotide sequence of the gene is shown in SEQ ID NO.
1.
2. A TaSMT-5B protein encoded by the gene TaSMT-5B as claimed in claim 1.
3. The TaSMT-5B protein encoded by the gene TaSMT-5B according to claim 2, characterized in that: The TaSMT-5B protein is as follows ( i )~(iv) one of the proteins shown: ( i ) The amino acid sequence of the protein is shown in SEQ ID NO.2; ( ii ) A protein derived from SEQ ID NO.2 with the same function as that of SEQ ID NO.2, wherein one or more amino acid residues are substituted and / or deleted and / or added; ( iii ) A protein having 99% or more, 95% or more, 90% or more, 85% or more or 80% or more homology with the amino acid sequence shown in SEQ ID NO.2 and its derivative protein and having the same function; (iv) A fusion protein obtained by connecting a tag to the N-terminus and / or C-terminus of the amino acid sequence shown in SEQ ID NO.2 and its derivative proteins or homologous proteins.
4. A recombinant vector containing the gene TaSMT-5B according to claim 1.
5. The recombinant vector of gene TaSMT-5B as claimed in claim 4, characterized in that: The nucleotide sequence of the recombinant vector is shown in SEQ ID NO.3, which is obtained by inserting the amino acid sequence encoded by the TaSMT-5B gene between the restriction endonucleases HindIII and BamHI in the multiple cloning site of the pCambia3300 backbone vector.
6. A transformant, characterized in that: Obtained by introducing the recombinant vector of claim 5 into a host cell, wherein the host cell is preferably an Escherichia coli cell or an Agrobacterium cell.
7. Use of the gene TaSMT-5B according to claim 1, the TaSMT-5B protein according to claim 2, the recombinant vector according to claim 4 or the transformant according to claim 6 in improving resistance to wheat fusarium head blight.
8. Use of the gene TaSMT-5B according to claim 1, the TaSMT-5B protein according to claim 2, the recombinant vector according to claim 4 or the transformant according to claim 6 in wheat breeding, characterized in that: A wheat variety that acquires significant disease resistance after introduction into plants.
9. The use according to claim 7, characterized in that: Overexpression of TaSMT-5B gene combined with inorganic selenium fertilization.
Citation Information
Patent Citations
Wheat gene capable of improving resistance to gibberellic disease of plant and applications of wheat gene
CN107058348A
Wheat scab-resistant gene TaXAX1 and application thereof
CN111269920A
Barley HvHMT3 gene and application thereof
CN112795545A
Application of TaSR45a gene in cultivating gibberellic disease resistant plant
CN114574520A
Broussonetia papyrifera homocysteine thiomethyltransferase gene BpHMT2 and application thereof
CN116286705A
